Yehuda Michael Rice serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Yehuda Michael Rice has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 29, 2023 involved receiving (via award) 7,885 shares valued at $0.
Yehuda Michael Rice currently holds 7,885 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yehuda Michael Rice has been a net neutral trader of NAVB stock. They have purchased $0 and sold $0 worth of shares.
Yehuda Michael Rice's most recent insider trade was on Mar 29, 2023, when they sold 7,885 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 6, 2020 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Feb 7, 2019 | NAVB | $0 | Award | 50,000 | $N/A | Discretionary |
| Feb 20, 2018 | NAVB | $0 | Award | 50,000 | $N/A | Discretionary |
| Sep 14, 2017 | NAVB | $0 | Gift | 28,000 | $N/A | Discretionary |
| Jun 30, 2017 | NAVB | $0 | Award | 50,000 | $N/A | Discretionary |
| Jun 14, 2016 | NAVB | $0 | Award | 28,000 | $N/A | Discretionary |